CR-CP Life Science Fund
Investor profile
CR-CP Life Science Fund has backed 2 European tech companies across 3 funding rounds between 2020 and 2022, joining rounds totalling €96M. Most active in Healthtech. Data as of Nov 2026.
Deals
3
distinct rounds
Companies
2
backed
Active span
2020–2022
3 yrs
Total round €
€96M
sum of rounds joined
Deals by year
distinct rounds / yearCR-CP Life Science Fund — deals by year — interactive chart.
Data table
| CR-CP Life Science Fund — deals by year | |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Top sectors
by dealsCR-CP Life Science Fund — top sectors — interactive chart.
Data table
| CR-CP Life Science Fund — top sectors | |
|---|---|
| Healthtech | 3 |
Stages
by dealsCR-CP Life Science Fund — stages — interactive chart.
Data table
| CR-CP Life Science Fund — stages | |
|---|---|
| Series B | 2 |
| Series C | 1 |
Countries
by dealsCR-CP Life Science Fund — countries — interactive chart.
Data table
| CR-CP Life Science Fund — countries | |
|---|---|
| Belgium | 2 |
| UK | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Novadip Biosciences | Belgium | 2 | €59M |
| ReViral | UK | 1 | €37M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Novadip Biosciences | Series B | €40M | 2022-11 |
| ReViral | Series C | €37M | 2020-08 |
| Novadip Biosciences | Series B | €19M | 2021-11 |